ZEISS Ventures

Overview

ZEISS Ventures is the corporate venture capital arm of the ZEISS Group, focusing on enabling and accelerating the development and commercialization of market-shaping innovations that are adjacent to or disruptive to ZEISS's existing business units. Their mission is to empower visionary founders by providing strategic resources, capital, and insights necessary to transform groundbreaking ideas into market-leading enterprises. As a strategic investor, ZEISS Ventures concentrates on ventures that are relevant to ZEISS, particularly in the fields of Industrial Technology, Medical Technology, and Life Sciences. They seek to invest in deep-tech startups with disruptive potential, aiming to drive innovation and create lasting value. Their investment strategy involves identifying and investing in external innovations and new business models for ZEISS, actively managing startup investments, and supporting early-stage business development efforts within ZEISS. With a strong presence in Germany and Finland, ZEISS Ventures has been involved in several notable investments, including leading an $8.9 million funding round for CREAL, a Swiss innovator in light field display technology, and supporting InSphero, a company specializing in 3D cell culture technology. These investments underscore ZEISS Ventures' commitment to fostering innovation and supporting the growth of transformative startups in sectors aligned with ZEISS's strategic interests.

Investment Focus

• Deep-tech startups with disruptive potential
• Alignment with ZEISS's strategic business units
• Focus on Industrial Technology, Medical Technology, and Life Sciences

Portfolio Companies